Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

3(50.0%)

N/A

3(50.0%)

6Total

Phase 2(3)

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06463275Completed

SpinChip Hs-cTnI Determination of the 99th Percentile URL

Role: collaborator

NCT06499519Completed

SpinChip Hs-cTnI Clinical Diagnostic Performance

Role: collaborator

NCT07279623Not ApplicableRecruiting

Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine

Role: collaborator

NCT05178134Phase 2Completed

A Phase 2 Bridging Study to Assess the New Formulation of ETVAX

Role: collaborator

NCT06851013Completed

SpinChip Hs-cTnI Multisite Precision

Role: collaborator

NCT06296953Not ApplicableCompleted

Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis

Role: collaborator

NCT06453707Completed

SpinChip Hs-cTnI Sample Type Validation

Role: collaborator

NCT05458050Not ApplicableCompleted

An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers

Role: collaborator

NCT05699486Phase 2Unknown

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Role: collaborator

NCT04102995Phase 2Completed

A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine

Role: collaborator

All 10 trials loaded